// App-Quantinova.ai

: The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG

Researchers

Presenter

  • Anna Schnell

Principal Investigators

  • David M. Lowe

  • Stefanie Graeter

  • Mehmet Davrandi

  • Siobhan O. Burns

  • Alexander Schaub

  • Moritz Saxenhofer

  • Maria Hauswald

  • Carolin Witte

  • Clara Leboreiro

  • Fernando Moreira

  • Irina Irincheeva

  • Ilka Schulze

  • Cedric Vonarburg

  • Annette Feussner

Medical Centers

  • Institute of Immunity and Transplantation, and Centre for Clinical Microbiology, University College, London, United Kingdom

  • Institute of Immunity and Transplantation, Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom

  • Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, United Kingdom

  • CSL Behring, Research Europe, Bern, Switzerland

  • CSL Behring GmbH, Research, Marburg, Germany

Locations

  • Germany

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Dysbiosis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Intratect

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved